S-aminosulfeniminopenicillins: Multimode β-lactamase inhibitors and template structures for penicillin-based β-lactamase substrates as prodrugs

Journal of Organic Chemistry

Volumn 63, Issue 22, 1998, Pages 7600-7618

  Smyth, Timothy P ^a   O'Donnell, Michael E ^a   O'Connor, Michael J ^a   St Ledger, James O ^a  

^a UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; N CARBETHOXY S AMINOSULFENIMINOPENICILLANATE 1 SULFONE; N METHYL N TOSYL S AMINOSULFENIMINOPENICILLANIC ACID; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; PRODRUG; S AMINOSULFENIMINOPENICILLIN DERIVATIVE; SULFONAMIDE; THIAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS CEREUS; CONTROLLED STUDY; DRUG POTENTIATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; ESCHERICHIA COLI; NONHUMAN;

EID: 0032582734     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo970737f     Document Type: Article

References (89)

1. Pratt, R. F. In The Chemistry of β-Lactams; Page, M. I., Ed.; Blackie Academic and Professional: Glasgow, 1992; Chapter 7.
2. (a) Bulychev, A.; Massova, I.; Lerner S. A.; Mobashery, S. J. Am. Chem. Soc. 1995, 117, 4797.
3. (b) Miyashita, K.; Massova, I.; Taibi, P.; Mobashery, S. J. Am. Chem. Soc. 1995, 117, 11055.
4. (a) Arisawa, M.; Adam, S. Biochem. J. 1983, 211, 447.
5. (b) Chen, Y. L.; Chang, C.-W.; Hedberg, K. Tetrahedron Lett. 1986, 27, 3449.
6. Chen, Y. L.; Chang, C.-W.; Hedberg, K.; Guarino, K.; Welch, W. M.; Messung, L.; Retsema, J. A.; Haskell, S. L.; Anderson, M.; Manuosos, M.; Barrett, J. F. J. Antibiot. 1987, 40, 803.
7. Bennett, I. S.; Brooks, G.; Broom, N. J. P.; Calvert, S. N.; Coleman, K.; Grancois, I. J. Antibiot. 1994, 44, 969.
8. (e) Buynak, J. D.; Khasnis, D.; Bachmann, B.; Wu, K.; Lamb, G. J. Am. Chem. Soc. 1994, 116, 10955.
9. (f) Buynak, J. D.; Geng, B.; Bachmann, B.; Hua, L. Bioorg. Med. Chem. Lett. 1995, 5, 1513.
10. The inherent reactivity of cephalosporins, resulting in elimination of the 3′ substitutent after cleavage of the β-lactam ring, has been harnessed in the development of dual-action structures producing effectively, cephalosporin based, β-lactamase substrate prodrugs: (a) O'Callaghan, C. H.; Sykes, R. B.; Staniforth, S. E. Antimicrob. Agents Chemother. 1976, 245.
11. (b) Mobashery, S.; Lerner, S. A.; Johnston, M.; J. Am. Chem. Soc. 1986, 108, 1685.
12. (c) Albrecht, H. A.; Beskid, G.; Christenson, J. G.; Durkin, J. W.; Fallat, V.; Georgopapadakou, N. H.; Keith, D. D.; Konzelmann, F. M.; Lipshitz, E. R.; McGarry, D. H.; Siebelist, J.-A, Wei, C.-C.; Weigele, M.; Yang, R. J. Med. Chem. 1991, 34, 669.
13. Albrecht, H. A.; Beskid, G.; Christenson, J. G.; Georgopapadakou, N. H.; Keith, D. D.; Konzelmann, F. M.; Pruess, D. L.; Rossman, P. L.; Wei, C.-C. J. Med. Chem. 1991, 34, 2857.
14. (e) Vrudhula, V. M.; Svensson, H. P.; Senter, P. D. J. Med. Chem. 1995, 38, 1380.
15. Bussas, R.; Kresze, G.; Munsterer, H.; Schwobel, A. In Sulfur Reports; Senning, A., Ed.; Harwood Academic Publishers: New York, 1983; Vol. 2 (6), p 215.
16. Sasaki, Y.; Olsen, F. P. Can. J. Chem. 1971, 41, 283.
17. Saito, T.; Hiraoka, T. Chem. Pharm. Bull. 1977, 25, 784.
18. (8) Included in Supporting Information.
19. Levy, G. C.; Lichter, R. L.; Nelson, G. L.; Eds. Carbon-13 Nuclear Magnetic Resonance Spectroscopy, 2nd ed.; John Wiley & Sons: New York, 1980; Chapter 5.
20. (a) Claus, P. K. In The Chemistry of Sulphenic Acids and Derivatives; Patai, S., Ed.; John Wiley & Sons: Chichester, 1990; Chapter 17.
21. 2, respectively: Davis, F. A.; Kluger, E. W. J. Am. Chem. Soc. 1976, 302.
22. Gordon, E. M.; Chang, H. W.; Cimarusti, C. M.; Toeplitz, B.; Gougoutas, J. Z. J. Am. Chem. Soc. 1980, 102, 1690.
23. Grigg, R.; McMeekin, P.; Sridharan, V. Tetrahedron 1995, 48, 13347.
24. Ampac 5.0, 1994, Semichem, 7204 Mullen, Shawnee, KS 66216. For details of SAM1 see: Dewar, J. S.; Jie, C.; Yu, J. Tetrahedron 1993, 49, 5003.
25. (a) Capozzi, C.; Modena, G.; Pasquato, L. In The Chemistry of Sulphenic Acids and Derivatives; Patai, S., Ed.; John Wiley & Sons: Chichester, 1990; Chapter 10.
26. (b) Hogg, D. R. In The Chemistry of Sulphenic Acids and Derivatives; Patai, S., Ed.; John Wiley & Sons: Chichester, 1990; Chapter 9.
27. Bryce, M. R. J. Chem. Soc., Perkin Trans. 1 1984, 2591.
28. (a) Kirby, A. J. Adv. Phys. Org. Chem. 1980, 183.
29. (b) Kirby, A. J.; Logan, C. J. J. Chem. Soc., Perkin Trans. 2 1978, 642.
30. (c) Menger, F. M. Acc. Chem. Res. 1985, 18, 128;
31. 1993, 26, 206.
32. (a) Bohme, H.; Sell, K. Chem. Ber. 1948, 81, 123.
33. (b) Bird, R.; Stirling, J. M. J. Chem. Soc., Perkin Trans. 2 1973, 1221 and references therein.
34. Armitage, D. A.; Clark. M. J.; Kisey, A. C. J. Chem. Soc. C 1971, 3867.
35. Davis, A. M.; Jones, M.; Page. M. I. J. Chem. Soc., Perkin Trans. 2 1991, 1219.
36. For examples of a similar pattern of chemical shift changes on opening the β-lactam ring of a penicillin followed by closure to yield bicyclic structures with the thiazolidine ring fused to five-membered rings, see: (a) Marchand-Brynaert, J.; Ghosez, L. Bull. Soc. Chim. Belg. 1985, 94, 1021.
37. (b) Tanaka, R.; Nakatsuka, T.; Ishiguro, M. Bioorg. Med. Chem. Lett. 1993, 3, 2299.
38. Davern, P.; Sheehy, J.; Smyth, T. J. Chem. Soc., Perkin Trans. 2 1994, 381 and references therein.
39. Claydon, N. J.; Dobson, C. M.; Lian, L.-Y.; Twyman, M. J. Chem. Soc., Perkin Trans. 1 1986, 1933.
40. Twyman, M.; Fattah, J.; Dobson, C. M. J. Chem. Soc., Chem. Commun. 1991, 647.
41. (a) Busson, R.; Vanderhaeghe, H. J. Org. Chem. 1976, 41, 2561.
42. (b) A number of other penicillin, and closely related, structures showing this pattern of chemical shifts for H5/H3 are given in Topics in Antibiotic Chemistry, Vol. 4; Sammes, P. G., Ed.; Ellis Horwood: Chichester, 1980; Chapter 2.
43. 3, but were able to so using the stronger base DBN.
44. (a) Tabushi, I.; Yoshinao, T.; Yoshida, Z.-i; Sugimoto, T. J. Am. Chem. Soc. 1975, 97, 2886.
45. Block, E. Reactions of Organosulfur Compounds; Academic Press: New York, 1978 Chapter 4 and references therein.
46. (b) deGroot, A.; Boerma, J. A.; Wynberg, H. Tetrahedron Lett, 1968, 2365.
47. Cerè, V.; Peri, F.; Pollicino, S.; Antonio, A. J. Chem. Soc., Perkin Trans. 2 1998, 977 and references therein.
48. - for a very short reaction time, see Experimental Section for details.
49. (b) The pKaα of a related compound, TsNHBoc, has been reported as 8.5 in DMSO: Koppel, I.; Koppel, J.; Degerbeck, F.; Grehn, L.; Ragnarsson, U. J. Org. Chem. 1991, 56, 7172.
50. (c) The ability of sulfur to stabilize an adjacent anion is well documented: Wiberg, K. B.; Castejon, H. J. Am. Chem. Soc. 1994, 116, 10489 and references therein.
51. Pouchert, C. J. The Aldrich Library of NMR Spectra, 2nd ed.; Aldrich Chemical Co., Inc.: Milwaukee, 1983; Vol. 2.
52. (a) Bassindale, A. R.; Iley, J. In The Chemistry of Sulphenic Acids and Derivatives; Patai, S., Ed.; John Wiley & Sons: Chichester, 1990; Chapter 3.
53. (b) Wenschuh, E.; Kuhne, U.; Mikolajczyk, M.; Bujnicki, B. Z. Chem. 1981, 21, 217.
54. Rao, S. N.; More O'Ferrall, R. A. J. Am. Chem. Soc. 1990, 112, 2729.
55. 5cm was isolated as the free acid. For enzymatic studies 50 μL of a THF solution of 5cm-free acid was added to the aqueous buffer containing the β-lactamase enzyme (see Experimental Section).
56. Walsh, C. Tetrahedron 1982, 38, 871.
57. Enzyme inactivation was found to be time dependent. An incubation time of 10 min proved to be convenient. The partition number, when evaluated in this way, can vary with the incubation time used: see ref 3e.
58. (a) Fersht, A., Ed. Enzyme Structure and Mechanism, 2nd ed.; W. H. Freeman and Company: New York, 1985; Chapter 3.
59. 3 which has been shown to be the case for a variety of β-lactamases (see ref 33).
60. Christensen, H.; Martin, M. T.; Waley, S. G. Biochem. J. 1990, 266, 853.
61. a of the N-conjugate acid of a closely related structure is 5.14: see ref 19.
62. For a definition and examples of site-specific-release prodrugs, see: Wermuth, C. G.; Gaignault, J.-C.; Marchandeau, C. In The Practice of Medicinal Chemistry; Wermuth, C. G., Ed.; Academic Press: London, 1996; Chapter 31.
63. m it is relevant to note than all penicillin-based structures which are good substrates of β-lactamase enzymes have a saturated carbon, with an R configuration and bearing a hydrogen atom, at C-6.
64. (a) Bush, K. In Antibiotic Resistance: Origins, Evolution, Selection and Spread; Wiley: Chichester (Ciba Foundation Symposium 207): 1997; p 152 and references therein.
65. (b) Neuhaus, F. C.; Georgopapadakou, N. H. In Emerging Targets in Antibacterial and Antifungal Chemotherapy, Sutcliffe, J., Georgopapadakou, N. H., Eds.; Chapman Hall: New York, 1992; Chapter 9 and references therein.
66. (a) Albery, W. J.; Knowles, J. R. Biochemistry 1976, 25, 5631.
67. (b) Albery, W. J.; Knowles, J. R. Angew. Chem., Int. Ed. Engl. 1977, 16, 285.
68. Smyth, T. P.; O'Donnell, M. E.; O'Connor, M. J.; St Ledger, J. O. Unpublished results.
69. In all cases no recovery of enzyme activity was detected after up to 19 h.
70. Knowles, J. R. Acc. Chem. Res. 1985, 18, 97.
71. Ishiguru, M.; Imajo, S. J. Am. Chem. Soc. 1996, 39, 2207 and references therein.
72. (43) (a) These tests were carried out by CPA Laboratories, Birkenhead, Wirral, U.K.
73. (44) These tests were carried out at the Centre for Research in AntiInfectives and Biotechnology, Creighton University, Omaha, NB.
74. (a) Nikaido, H.; Rosenberg, E. Y. J. Bacteriol. 1983, 753, 241.
75. (b) Nikaido, H.; Rosenberg, E. Y.; Foulds, J. J. Bacteriol. 1983, 153, 232.
76. Nikaido, H.; Pharmacol. Ther. 1985, 27, 231.
77. Teng, M.; Miller, M. J.; Nicas, T. I.; Grissom-Arnold, J.; Cooper, R. D. G. Biorg. Med. Chem. Lett. 1993, 1, 151.
78. Buynak, J. D.; Geng, B.; Bachmann, B.; Hua, L. Biorg. Med. Chem. Lett. 1995, 5, 1513.
79. Casey, M.; Leonard, J.; Lygo B.; Procter, G. Advanced Practical Organic Chemistry, Blackie: Glasgow, 1990; Chapter 9.
80. Hanson. P.; Stockburn, W. A. J. Chem. Soc., Perkin Trans. 2 1985, 589.
81. Kresze, G.; Wucherpfennig, W. Angew. Chem., Int. Ed. Engl. 1967, 6, 149.
82. This is a modification of the procedure reported in Katz, T. J.; Shi, S. J. Org. Chem. 1994, 59, 8297.
83. This is a modification of the procedure reported in ref 50.
84. Petrusson, S.; Walley, S. G. Tetrahedron 1983, 39, 2465.
85. Buynak, J. D.; Khasnis, D.; Bachmann, B.; Wu, K.; Lamb, G. J. Am. Chem. Soc. 1994, 166, 10955.
86. James, A. M.; Lord, M. P. Macmillan's Chemical and Physical Data; The Macmillan Press: London, 1992.
87. Buckwell, S. C.; Page, M. I. J. Chem. Soc., Perkin Trans. 2 1988, 1809.
88. Kiener, P. A.; Knott-Hunziker, V.; Petursson, S.; Walcy, S. G. Eur. J. Biochem. 1980, 109, 575.
89. Bush, K.; Jacoby, G. A.; Medeiros, A. A. Antimicrob. Agents Chemother. 1995, 39, 1211.